 Jill Fattor
Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lumbar Vertebrae | 3 | 2018 | 230 | 0.600 |
Why?
| | Physical Endurance | 9 | 2013 | 269 | 0.550 |
Why?
| | Exercise | 14 | 2013 | 1947 | 0.530 |
Why?
| | Total Disc Replacement | 1 | 2016 | 14 | 0.510 |
Why?
| | Lactic Acid | 9 | 2013 | 295 | 0.510 |
Why?
| | Intervertebral Disc | 1 | 2016 | 39 | 0.500 |
Why?
| | Models, Anatomic | 1 | 2016 | 92 | 0.490 |
Why?
| | Recovery of Function | 3 | 2016 | 648 | 0.410 |
Why?
| | Oxygen Consumption | 10 | 2013 | 675 | 0.250 |
Why?
| | Lactates | 2 | 2006 | 83 | 0.250 |
Why?
| | Epinephrine | 2 | 2009 | 138 | 0.240 |
Why?
| | Physical Fitness | 3 | 2013 | 203 | 0.240 |
Why?
| | Energy Metabolism | 10 | 2010 | 836 | 0.230 |
Why?
| | Gluconeogenesis | 4 | 2013 | 73 | 0.220 |
Why?
| | Norepinephrine | 1 | 2004 | 209 | 0.210 |
Why?
| | Postmenopause | 3 | 2010 | 370 | 0.210 |
Why?
| | Blood Glucose | 7 | 2013 | 2096 | 0.190 |
Why?
| | Indocyanine Green | 1 | 2001 | 19 | 0.190 |
Why?
| | Fatty Acids, Nonesterified | 4 | 2010 | 159 | 0.170 |
Why?
| | Muscle, Skeletal | 5 | 2007 | 1640 | 0.170 |
Why?
| | Lipolysis | 2 | 2010 | 40 | 0.160 |
Why?
| | Spondylolisthesis | 1 | 2018 | 8 | 0.150 |
Why?
| | Physical Exertion | 3 | 2004 | 212 | 0.150 |
Why?
| | Glycogenolysis | 3 | 2013 | 8 | 0.150 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2018 | 33 | 0.150 |
Why?
| | Antioxidants | 3 | 2006 | 543 | 0.140 |
Why?
| | Exercise Test | 6 | 2013 | 615 | 0.140 |
Why?
| | Mechanical Phenomena | 1 | 2018 | 83 | 0.140 |
Why?
| | Carbon Dioxide | 3 | 2013 | 262 | 0.130 |
Why?
| | Polyethylene Glycols | 1 | 2001 | 597 | 0.130 |
Why?
| | Finite Element Analysis | 1 | 2016 | 72 | 0.130 |
Why?
| | Triglycerides | 2 | 2010 | 524 | 0.120 |
Why?
| | Spinal Fusion | 1 | 2018 | 231 | 0.120 |
Why?
| | Glycerol | 4 | 2010 | 87 | 0.120 |
Why?
| | Anaerobic Threshold | 1 | 2013 | 27 | 0.110 |
Why?
| | Hypoxia | 2 | 2013 | 1035 | 0.110 |
Why?
| | Cardiovascular Physiological Phenomena | 2 | 2012 | 44 | 0.110 |
Why?
| | Lipid Peroxidation | 4 | 2007 | 143 | 0.100 |
Why?
| | Rest | 6 | 2012 | 123 | 0.100 |
Why?
| | Physical Conditioning, Human | 1 | 2013 | 39 | 0.100 |
Why?
| | Respiration | 3 | 2009 | 191 | 0.100 |
Why?
| | Imaging, Three-Dimensional | 1 | 2016 | 535 | 0.100 |
Why?
| | Models, Biological | 2 | 2018 | 1695 | 0.100 |
Why?
| | Altitude | 2 | 2006 | 447 | 0.100 |
Why?
| | Adult | 20 | 2018 | 35510 | 0.090 |
Why?
| | Oxidation-Reduction | 6 | 2013 | 1002 | 0.090 |
Why?
| | Glucose | 2 | 2012 | 983 | 0.080 |
Why?
| | Insulin | 4 | 2013 | 2320 | 0.080 |
Why?
| | Humans | 26 | 2018 | 129116 | 0.070 |
Why?
| | Male | 21 | 2018 | 63194 | 0.070 |
Why?
| | Fatty Acids | 2 | 2007 | 415 | 0.070 |
Why?
| | Sodium Bicarbonate | 1 | 2007 | 39 | 0.070 |
Why?
| | Pulmonary Ventilation | 1 | 2007 | 76 | 0.070 |
Why?
| | Maximal Voluntary Ventilation | 1 | 2006 | 8 | 0.070 |
Why?
| | Kinetics | 4 | 2013 | 1617 | 0.070 |
Why?
| | Lipid Metabolism | 2 | 2006 | 493 | 0.060 |
Why?
| | Liver | 2 | 2012 | 1833 | 0.060 |
Why?
| | Cholesterol, HDL | 1 | 2006 | 203 | 0.060 |
Why?
| | Sodium Lactate | 1 | 2004 | 5 | 0.060 |
Why?
| | Acid-Base Equilibrium | 1 | 2004 | 28 | 0.060 |
Why?
| | Cholesterol, LDL | 1 | 2006 | 361 | 0.060 |
Why?
| | C-Reactive Protein | 1 | 2006 | 397 | 0.050 |
Why?
| | Sympathetic Nervous System | 1 | 2004 | 184 | 0.050 |
Why?
| | Altitude Sickness | 1 | 2004 | 137 | 0.050 |
Why?
| | Muscle Contraction | 1 | 2006 | 421 | 0.050 |
Why?
| | Blood Proteins | 1 | 2004 | 240 | 0.050 |
Why?
| | Infusions, Intravenous | 3 | 2010 | 385 | 0.050 |
Why?
| | Heart Rate | 2 | 2006 | 808 | 0.050 |
Why?
| | Indicator Dilution Techniques | 1 | 2001 | 11 | 0.050 |
Why?
| | Interleukin-6 | 1 | 2006 | 718 | 0.050 |
Why?
| | Spectrophotometry | 1 | 2001 | 58 | 0.050 |
Why?
| | Young Adult | 5 | 2018 | 12389 | 0.050 |
Why?
| | Indicators and Reagents | 1 | 2001 | 105 | 0.050 |
Why?
| | Metabolic Clearance Rate | 2 | 2013 | 103 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2006 | 1192 | 0.040 |
Why?
| | Leg | 3 | 2007 | 242 | 0.040 |
Why?
| | Aging | 1 | 2010 | 1771 | 0.040 |
Why?
| | Plasma | 1 | 2001 | 201 | 0.040 |
Why?
| | Palmitic Acid | 2 | 2010 | 40 | 0.040 |
Why?
| | Carbon Isotopes | 2 | 2010 | 123 | 0.040 |
Why?
| | Apolipoproteins | 2 | 2010 | 38 | 0.040 |
Why?
| | Middle Aged | 6 | 2018 | 31074 | 0.040 |
Why?
| | Lumbosacral Region | 1 | 2018 | 58 | 0.040 |
Why?
| | Oxidative Stress | 1 | 2004 | 1192 | 0.040 |
Why?
| | Operative Time | 1 | 2018 | 122 | 0.040 |
Why?
| | Lordosis | 1 | 2018 | 14 | 0.040 |
Why?
| | Blood Loss, Surgical | 1 | 2018 | 91 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2010 | 2024 | 0.040 |
Why?
| | Costs and Cost Analysis | 1 | 2018 | 209 | 0.040 |
Why?
| | Posture | 1 | 2018 | 176 | 0.030 |
Why?
| | Elective Surgical Procedures | 1 | 2018 | 163 | 0.030 |
Why?
| | Double-Blind Method | 3 | 2006 | 1865 | 0.030 |
Why?
| | Female | 10 | 2018 | 68510 | 0.030 |
Why?
| | Low Back Pain | 1 | 2018 | 105 | 0.030 |
Why?
| | Adolescent | 5 | 2007 | 20301 | 0.030 |
Why?
| | Blood Pressure | 1 | 2002 | 1735 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 2018 | 780 | 0.030 |
Why?
| | Regional Blood Flow | 2 | 2006 | 463 | 0.030 |
Why?
| | Body Weight | 2 | 2010 | 932 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2006 | 1271 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2013 | 269 | 0.030 |
Why?
| | Sex Characteristics | 2 | 2008 | 727 | 0.030 |
Why?
| | Pressure | 1 | 2013 | 240 | 0.020 |
Why?
| | Glucose Tolerance Test | 1 | 2013 | 356 | 0.020 |
Why?
| | Hormones | 1 | 2012 | 140 | 0.020 |
Why?
| | Body Composition | 2 | 2006 | 657 | 0.020 |
Why?
| | Homeostasis | 2 | 2008 | 605 | 0.020 |
Why?
| | Sex Factors | 2 | 2010 | 1953 | 0.020 |
Why?
| | Fasting | 1 | 2012 | 264 | 0.020 |
Why?
| | Esterification | 1 | 2010 | 9 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2613 | 0.020 |
Why?
| | Diet Records | 1 | 2010 | 80 | 0.020 |
Why?
| | Bicycling | 1 | 2010 | 118 | 0.020 |
Why?
| | Basal Metabolism | 1 | 2009 | 57 | 0.020 |
Why?
| | Walking | 1 | 2013 | 500 | 0.020 |
Why?
| | Oxygen | 1 | 2013 | 902 | 0.020 |
Why?
| | Glucagon | 1 | 2009 | 105 | 0.020 |
Why?
| | Time Factors | 2 | 2010 | 6518 | 0.020 |
Why?
| | Cholesterol | 1 | 2010 | 406 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 2541 | 0.020 |
Why?
| | Down-Regulation | 1 | 2010 | 634 | 0.020 |
Why?
| | Growth Hormone | 1 | 2007 | 96 | 0.020 |
Why?
| | Whole-Body Counting | 1 | 2006 | 6 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2018 | 2496 | 0.020 |
Why?
| | Pyruvates | 1 | 2006 | 23 | 0.020 |
Why?
| | Body Weights and Measures | 1 | 2006 | 34 | 0.020 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2006 | 116 | 0.020 |
Why?
| | Pulmonary Gas Exchange | 1 | 2006 | 117 | 0.020 |
Why?
| | Femoral Artery | 1 | 2007 | 174 | 0.020 |
Why?
| | Lipoproteins, LDL | 1 | 2006 | 126 | 0.020 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2006 | 95 | 0.020 |
Why?
| | Catecholamines | 1 | 2006 | 97 | 0.020 |
Why?
| | Hydrocortisone | 1 | 2007 | 304 | 0.020 |
Why?
| | Muscle Fatigue | 1 | 2006 | 101 | 0.010 |
Why?
| | Insulin Resistance | 1 | 2013 | 1167 | 0.010 |
Why?
| | Workload | 1 | 2006 | 152 | 0.010 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2006 | 190 | 0.010 |
Why?
| | Hematocrit | 1 | 2004 | 94 | 0.010 |
Why?
| | Glycolysis | 1 | 2006 | 293 | 0.010 |
Why?
| | Placebos | 1 | 2004 | 201 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2018 | 10226 | 0.010 |
Why?
| | Energy Intake | 1 | 2006 | 455 | 0.010 |
Why?
| | Glycogen | 1 | 2002 | 55 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 2002 | 164 | 0.010 |
Why?
| | DNA Damage | 1 | 2004 | 364 | 0.010 |
Why?
| | Reference Values | 1 | 2002 | 780 | 0.010 |
Why?
| | Adaptation, Physiological | 1 | 2004 | 515 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2018 | 14571 | 0.010 |
Why?
| | Body Mass Index | 1 | 2008 | 2266 | 0.010 |
Why?
| | Aged | 1 | 2018 | 22083 | 0.010 |
Why?
| | Heart | 1 | 2002 | 639 | 0.010 |
Why?
| | Biomarkers | 1 | 2010 | 3896 | 0.010 |
Why?
| | Weight Loss | 1 | 2002 | 724 | 0.010 |
Why?
| | Diet | 1 | 2004 | 1204 | 0.010 |
Why?
| | Prospective Studies | 1 | 2006 | 7079 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2006 | 5376 | 0.010 |
Why?
| | Animals | 1 | 2006 | 34600 | 0.000 |
Why?
|
|
Fattor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|